These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3156286)

  • 1. The putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin antagonizes the antinociceptive effect of morphine.
    Berge OG; Fasmer OB; Ogren SO; Hole K
    Neurosci Lett; 1985 Feb; 54(1):71-5. PubMed ID: 3156286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-hydroxytryptamine (HT)1A receptors and the tail-flick response. II. High efficacy 5-HT1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner.
    Millan MJ; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):983-92. PubMed ID: 1672380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Engel JA; Hjorth S; Svensson K; Carlsson A; Liljequist S
    Eur J Pharmacol; 1984 Oct; 105(3-4):365-8. PubMed ID: 6239785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the putative 5-HT1A receptor agonist 8-OH-2-(di-n-propylamino)tetralin on nociceptive sensitivity in mice.
    Fasmer OB; Berge OG; Post C; Hole K
    Pharmacol Biochem Behav; 1986 Oct; 25(4):883-8. PubMed ID: 2947249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
    Arvidsson LE; Johansson AM; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Magnusson T; Carlsson A; Andersson B; Wikström H
    J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Yamada J; Sugimoto Y; Horisaka K
    Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subsensitivity of serotonin and substance P receptors involved in nociception after repeated administration of a serotonin receptor agonist.
    Eide PK; Hole K
    J Neural Transm; 1989; 77(1):1-10. PubMed ID: 2545812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of lordosis behavior by the putative 5-HT receptor agonist 8-OH-DPAT in the rat.
    Ahlenius S; Fernandez-Guasti A; Hjorth S; Larsson K
    Eur J Pharmacol; 1986 May; 124(3):361-3. PubMed ID: 2942412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-Hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis.
    Invernizzi RW; Cervo L; Samanin R
    Neuropharmacology; 1988 May; 27(5):515-8. PubMed ID: 2969083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the 5-hydroxytryptamine receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in different rodent models of epilepsy.
    Löscher W; Czuczwar SJ
    Neurosci Lett; 1985 Sep; 60(2):201-6. PubMed ID: 2932661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to antagonize the 8-hydroxy-2-di-n-propylamino)tetralin-induced facilitation of male rat sexual behavior by the administration of 5-HT receptor antagonists.
    Ahlenius S; Larsson K
    Eur J Pharmacol; 1984 Apr; 99(4):279-86. PubMed ID: 6234182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Mellin C; Björk L; Karlén A; Johansson AM; Sundell S; Kenne L; Nelson DL; Andén NE; Hacksell U
    J Med Chem; 1988 Jun; 31(6):1130-40. PubMed ID: 2967376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.
    Hjorth S; Sharp T; Hacksell U
    Eur J Pharmacol; 1989 Nov; 170(3):269-74. PubMed ID: 2533557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N,N-di-n-propylserotonin: binding at serotonin binding sites and a comparison with 8-hydroxy-2-(di-n-propylamino)tetralin.
    Glennon RA; Titeler M; Lyon RA; Slusher RM
    J Med Chem; 1988 Apr; 31(4):867-70. PubMed ID: 2965244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential antidepressant properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist.
    Cervo L; Samanin R
    Eur J Pharmacol; 1987 Dec; 144(2):223-9. PubMed ID: 2963752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A C2-methylated derivative of the 5-hydroxy-tryptamine-receptor agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH DPAT).
    Mellin C; Liu Y; Hacksell U; Björk L; Andén NE
    Acta Pharm Suec; 1987; 24(4):153-60. PubMed ID: 2964167
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin 1A receptor agonist.
    Carli M; Samanin R
    Psychopharmacology (Berl); 1988; 94(1):84-91. PubMed ID: 2894704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on central 5-hydroxytryptamine receptors.
    Björk L; Mellin C; Hacksell U; Andén NE
    Eur J Pharmacol; 1987 Nov; 143(1):55-63. PubMed ID: 2961582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.